Simulations Plus, Inc. Banner Image

Simulations Plus, Inc.

  • Ticker SLP
    Exchange NASDAQ More
  • Industry Healthcare Information Services More
  • Sector Healthcare More
Simulations Plus, Inc. Logo Image
  • 51-200 Employees
  • Based in Lancaster, California
Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. They partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinicalMore trials/post approval. With their subsidiaries, Cognigen Corporation and DILIsym Services, they offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, KIWI™, DILIsym®, NAFLDsym®, PKPlus™, and more) to bridge data mining, compound library screening with QSAR models, PBPK/TK modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. Simulations Plus technology is licensed to and used by regulatory agencies worldwide.
4.8 / 5.0 (92)

Simulations Plus, Inc. reports have an aggregate usefulness score of 4.8 based on 92 reviews.

Simulations Plus, Inc.

Most Recent Annual Report

Simulations Plus, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Simulations Plus, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!